Corporate Actions Concentric delisting last day of trading on Nasdaq Stockholm (takeover) Dicot Pharma first day of trading on First North after moving from Spotlight Mavshack excluding right N 2:1, 8 öre per share Opticept excluding right N 5:16, SEK 5 per share Sarsys excluding right N 1:1, SEK 1.65 per share
Other events 07:00 Clas Ohlson monthly sales
Foreign other events China iron ore imports 07:30 DFDS monthly report 08:00 Finnair passenger statistics
MAKRO China trade balance China foreign exchange reserves 01:30 Australia trade balance 03:00 Philippines GDP quarterly 07:00 Estonia CPI 08:00 Denmark industrial production 08:00 Norway industrial production 08:00 Romania retail sales 08:00 United Kingdom house price index Halifax 08:00 Sweden CPI preliminary 08:00 Sweden central government payments (National Debt Office) 08:00 Germany trade balance 08:00 Germany industrial production 08:30 Hungary retail sales 08:35 ECB speech by Stournaras 09:00 Spain industrial production 09:00 Czech Republic retail trade 09:10 ECB speech by Schnabel 09:30 EMU PMI construction 09:30 France construction PMI 09:30 Italy construction PMI 09:30 Riksbank interest rate announcement 09:30 Riksbank monetary policy update 09:30 Germany construction PMI 10:00 Norway interest rate announcement 10:00 Riksbank press conference after interest rate decision 11:00 EMU retail sales 12:00 Ireland CPI 13:00 Bank of England interest rate announcement 13:00 Mexico CPI 14:30 ECB speech by Lane 14:30 Czech Republic interest rate announcement 14:30 USA number of new unemployed, weekly statistics 14:30 US productivity preliminary 15:30 ECB speech by Lane 15:30 ECB speech by Stournaras 16:00 USA wholesale inventories revised 16:00 USA wholesale sales 16:30 USA EIA weekly natural gas inventories 16:45 ECB speech by Stournaras 20:00 Argentina industrial production 20:00 Federal Reserve interest rate statement 20:30 Federal Reserve press conference
Camurus AB is a Sweden-based research and development based pharmaceutical and biotechnology company with a focus on the development and marketing of specialty medicines, providing patients suffering from severe and chronic disease, such as opioid dependence, pain, cancer, and endocrine diseases. The Company has a diversified research portfolio, which includes products in clinical trials. The Companyâs products are based on FluidCrystal formulation technology. FluidCrystal is Company's patent-protected technology platform. Camurus AB is the parent company of the Group, which comprises of legal entities, namely: Camurus Inc, Cubosome Inc, Development AB, Camurus GmbH, Camurus Ltd, Camurus Oy, Camurus AS, Camurus SAS, Camurus Pty Ltd, Camurus S.L, Camurus ApS, Camurus BV and Camurus Austria GmbH.
This super rating is the result of a weighted average of the rankings based on the following ratings: Global Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Global Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite), and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
Quality
Quality
This composite rating is the result of an average of the rankings based on the following ratings: Capital Efficiency (Composite), Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.